These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6849644)

  • 1. Ocular penetration of amikacin following intramuscular injection.
    Wingfield DL; McDougal RL; Roy FH; Hanna C
    Arch Ophthalmol; 1983 Jan; 101(1):117-20. PubMed ID: 6849644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Penetration of amikacin into the anterior chamber of the human eye].
    Barrera V; Sinues B; Martinez P; Buatas A; Pinero A
    J Fr Ophtalmol; 1984; 7(8-9):539-43. PubMed ID: 6520334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of amikacin into the aphakic eye.
    Kasbeer RT; Peyman GA; May DR; Homer PI
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Aug; 196(1):85-94. PubMed ID: 1080641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of amikacin (BB-K8) in ophthalmological field (author's transl)].
    Hatano H; Tokuda H; Kayaba C
    Jpn J Antibiot; 1974 Aug; 27(4):451-5. PubMed ID: 4548096
    [No Abstract]   [Full Text] [Related]  

  • 5. Amikacin levels in human aqueous humor.
    Radda TM; Gnad HD; Graninger W; Rameis H
    Arzneimittelforschung; 1983; 33(11):1607-8. PubMed ID: 6686458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BB-K 122: in vitro and in vivo activity against ocular pathogens.
    Schlech BA; Cagle GD
    Curr Eye Res; 1981; 1(7):409-17. PubMed ID: 6797791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous-humor concentrations of amikacin.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1983 Jul; 101(7):1145-6. PubMed ID: 6870637
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory studies with amikacin in newborns, infants, and children.
    Trujillo H; Manotas R; Londono R; Ramirez JI; Uribe A; De Vidal EL; Agudelo N
    J Infect Dis; 1976 Nov; 134 SUPPL():S406-11. PubMed ID: 993632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental studies on topic application of amikacin to the eye (author's transl)].
    Krasemann C; Mester U; Stein HJ
    Arzneimittelforschung; 1978; 28(9):1602-4. PubMed ID: 582564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular penetration of amikacin. Iris binding and bioavailability.
    Eiferman RA; Stagner JI
    Arch Ophthalmol; 1982 Nov; 100(11):1817-9. PubMed ID: 7138350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
    Lobuseva AN; Kuznetsova SM; Samoĭlova LN
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin therapy for serious gram-negative infection.
    Pollock AA; Berger SA; Richmond AS; Simberkoff MS; Rahal JJ
    JAMA; 1977 Feb; 237(6):562-4. PubMed ID: 576282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of amikacin sulfate (Amikin). A new aminoglycoside antibiotic.
    Schiffman DO
    JAMA; 1977 Oct; 238(14):1547-50. PubMed ID: 578232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.
    Moody MM; de Jongh CA; Schimpff SC; Tillman GL
    JAMA; 1982 Sep; 248(10):1199-202. PubMed ID: 6809965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra aqueous humor penetration of ciprofloxacin in humans].
    Bron A; Talon D; Cellier T; Estavoyer JM; Delbosc B; Royer J
    Pathol Biol (Paris); 1989 Jun; 37(6):730-3. PubMed ID: 2780111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of kanamycin and amikacin in human gallbladder bile and wall.
    Hansbrough JF; Clark JE; Reimer LG
    Antimicrob Agents Chemother; 1981 Oct; 20(4):515-7. PubMed ID: 7342877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results.
    Faragó E; Kiss J; Gömöry A; Aranyosi J; Juhász I; Mihóczy L
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):421-8. PubMed ID: 511416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.